Sebastian Serfling
Overview
Explore the profile of Sebastian Serfling including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
117
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Michalski K, Schlotelburg W, Hartrampf P, Heinrich M, Serfling S, Buck A, et al.
Mol Imaging Biol
. 2024 Feb;
26(2):344-350.
PMID: 38332341
Background: Gastro-entero-pancreatic neuroendocrine carcinomas (GEP-NECs) are an aggressive subgroup of neuroendocrine neoplasms (NENs). In patients affected with NEN, there is a growing body of evidence that increased C-X-C motif chemokine...
2.
Frohlich M, Serfling S, Higuchi T, Pomper M, Rowe S, Schmalzing M, et al.
Diagnostics (Basel)
. 2021 Nov;
11(11).
PMID: 34829421
The 2-deoxy-d-[F]fluoro-D-glucose (FDG) positron emission tomography/computed tomography (PET/CT) is widely utilized to assess the vascular and articular inflammatory burden of patients with a suspected diagnosis of rheumatic disease. We aimed...
3.
Giesel F, Kratochwil C, Schlittenhardt J, Dendl K, Eiber M, Staudinger F, et al.
Eur J Nucl Med Mol Imaging
. 2021 Jun;
48(13):4377-4385.
PMID: 34137945
Purpose: FAPI ligands (fibroblast activation protein inhibitor), a novel class of radiotracers for PET/CT imaging, demonstrated in previous studies rapid and high tumor uptake. The purpose of this study is...
4.
Linz C, Brands R, Kertels O, Dierks A, Brumberg J, Gerhard-Hartmann E, et al.
Eur J Nucl Med Mol Imaging
. 2021 May;
48(12):3951-3960.
PMID: 34050405
Purpose: While [F]-fluorodeoxyglucose ([F]FDG) is the standard for positron emission tomography/computed tomography (PET/CT) imaging of oral squamous cell carcinoma (OSCC), diagnostic specificity is hampered by uptake in inflammatory cells such...
5.
Schumann S, Scherthan H, Lapa C, Serfling S, Muhtadi R, Lassmann M, et al.
Eur J Nucl Med Mol Imaging
. 2019 Apr;
46(8):1723-1732.
PMID: 31028426
Purpose: The aim of this study was to investigate the time- and dose-dependency of DNA double-strand break (DSB) induction and repair in peripheral blood leucocytes of prostate cancer patients during...
6.
Serfling S, Luther A, Kosmala A, Bluemel C
Clin Nucl Med
. 2016 Jun;
41(10):792-3.
PMID: 27355849
Here, we report on a 73-year-old man with a biochemical relapse (PSA level, 1.1 ng/mL) 8 years after radical prostatectomy and radiotherapy. Four years after primary diagnosis, a bilateral subcapsular...